Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia: Identification of different susceptibility haplotypes

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 953-961

  Dallinga Thie, Geesje M ^a   Van Linde Sibenius Trip, Margreet ^a   Rotter, Jerome I ^b   Cantor, Rita M ^b   Bu, Xiang Dong ^b   Lusis, Aldons J ^c   De Bruin, Tjerk W A ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

apolipoprotein B; apolipoprotein CIII; familial combined hyperlipidemia; gene gene interaction; genetic linkage analysis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EPISTASIS; FAMILIAL HYPERLIPEMIA; FEMALE; GENE CLUSTER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030937346     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119260     Document Type: Article

References (52)

1. Goldstein, J.L., H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky. 1973. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52:1544-1568.
2. Castro Cabezas, M., T.W.A. do Bruin, and D.W. Erkelens. 1992. Familial combined hyperlipidemia: 1973-1991. Neth. J. Med. 40:83-95.
3. Iselius, L. 1981. Complex segregation analysis of hypertriglyceridemia. Hum. Hered. 31:222-226.
4. Williams, W.R., and J.M. Lalouel. 1982. Complex segregation analysis of hyperlipidemia in a Seattle sample. Hum. Hered. 32:24-36.
5. Cullen, P., B. Farren, J. Scott, and M. Farrall. 1994. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 british families with familial combined hyperlipidemia. Arterioscler. Thromb. 14:1233-1249.
6. Dallinga-Thie, G.M., X.D. Bu, M. Van Linde-Sibenius Trip, J.I. Rotter, A.J. Lusis, and T.W.A. De Bruin. 1996. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37:136-147.
7. Brunzell, J.D., J.J. Albers, A. Chait, S.M. Grundy, E. Groszek, and G.B. McDonald. 1983. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res. 24:147-155.
8. Kwiterovich, P.O. 1993. Genetics and molecular biology of familial combined hyperlipidemia. Curr. Opin. Lipidol. 4:133-143.
9. Kissebah, A.H., S. Alfarsi, and P.W. Adams. 1981. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metab. Clin. Exp. 30:856-868.
10. Cortner, J.A., P.M. Coates, M.J. Bennett, D.R. Cryer, and N.-A. Le. 1991. Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very low density apolipoprotein B by the liver. J. Inherited Metab. Dis. 14:915-922.
11. Venkatesan, S., P. Cullen, P. Pacy, D. Halliday, and J. Scott. 1993. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb. 13:1110-1118.
12. Austin, M.A., J.D. Brunzell, W.L. Fitch, and R.M. Krauss. 1990. Inheritence of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arterioscler. Thromb. 10:520-530.
13. Jarvik, G.P., J.D. Brunzell, M.A. Austin, R.M. Krauss, A.G. Motulsky, and E. Wijsman. 1994. Genetic predictors of FCHL in four large pedigrees: Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler. Thromb. 14:1687-1694.
14. Bredie, S.J.H., L.A. Kiemeney, A.F.J. de Haan, P.N.M. Demacker, and A.F.H. Stalenhoef. 1996. Inherited susceptibility determines the distribution of dense low-density lipoprotein subtraction profiles in familial combined hyperlipidemia. Am. J. Hum. Genet. 58:812-822.
15. Rauh, G., H. Schuster, B. Muller, S. Schewe, C. Keller, G. Wolfram, and N. Zollner. 1990. Genetic evidence from seven families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 83: 81-87.
16. Coresh, J., T.H. Beaty, P.O. Kwiterovich, and S.E. Antonarakis. 1992. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am. J. Hum. Genet. 50:1038-1045.
17. Babirak, S.P., B.G. Brown, and J.D. Brunzell. 1992. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler. Thromb. 12: 1176-1183.
18. Nevin, D.N., J.D. Brunzell, and S.S. Deeb. 1994. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler. Thromb. 14:869-873.
19. Gagne, E., J. Genest, H. Zhang, L.A. Clarke, and M.R. Hayden. 1994. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler. Thromb. 14:1250-1257.
20. Reymer, P.W.A., B.E. Groenemeyer, E. Gagne, L. Miao, E.E.G. Appelman, J.C. Seidel, D. Kromhout, S.M. Bijvoet, K. Van de Oever, T. Bruin, et al. 1995. A frequently occurring mutation in the lipoprotein lipase gene(Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4:1543-1549.
21. Hoffer, M.J.V., S.J.H. Bredie, D.I. Boomsma, P.W.A. Reymer, J.J.P. Kastelein, P. de Knijff, P.N.M. Demacker, A.F.H. Stalenhoef, L.M. Havekes, and R.R. Frants. 1996. The lipoprotein lipase (Asn291-Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidemia. Atherosclerosis. 119:159-168.
22. Mailly, F., Y. Tugrul, P.W.A. Reymer, T. Bruin, M. Seed, B.F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A.F. Winder, G.J. Miller, et al. 1995. A common variant in the gene for lipoprotein lipase (Asp9→Asn): Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. 15:468-478.
23. Wojciechowski, A.P., M. Farrall, P. Cullen, T.M.E. Wilson, J.D. Bayliss, B.A. Griffin, M.D. Caslake, C.J. Packard, J. Shepherd, R. Thakker, et al. 1991. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature (Lond.). 349:161-164.
24. Wijsman, E.M., A.G. Motulsky, S.W. Guo, M. Yang, M.A. Austin, J.D. Brunzell, and S. Deeb. 1992. Evidence against linkage of familial combined hyperlipidemia to the apo AI-CIII-AIV gene complex. Circulation. 86:I 420.
25. Hayden, M.R., H. Kirk, H. Campbell, J. Frohlich, S. Rabkin, R. McLeod, and J. Hewitt. 1987. DNA polymorphism in and around the apo AI-CIII genes and genetic hyperlipidemia. Am. J. Hum. Genet. 40:421-430.
26. Galton, D.J. 1988. Molecular genetics of coronary heart disease. Eur. J. Clin. Invest. 18:219-225.
27. Ordovas, J.M., F. Civeira, J.R. Genest, S. Craig, A.H. Robbins, T. Meade, M. Pocovi, P.M. Frossard, U. Masharani, P.W. Wilson, et al. 1991. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 87:75-86.
28. Paulweber, B., W. Friedl, F. Krempler, S.E. Humphries, and F. Sandhofer. 1988. Genetic variation in the apolipoprotein A-IC-IIIA-IV gene cluster and coronary heart disease. Atherosclerosis. 73:125-133.
29. Tybjaerg-Hansen, A., B.G. Nordestgaard, L.U. Gerdes, O. Faergeman, and S.E. Humphries. 1993. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis. 100:157-169.
30. Castro Cabezas, M., T.W.A. de Bruin, H.A. de Valk, C.C. Shoulders, H. Jansen, and D.W. Erkelens. 1993. Impaired fatty acid metabolism in familial combined hyperlipidemia. J. Clin. Invest. 92:160-168.
31. De Bruin, T.W.A., C.B. Brouwer, J.A. Gimpel, and D.W. Erkelens. 1991. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am. J. Physiol. 260:492-498.
32. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16: 1215.
33. Terwilliger, J.D., and J. Ott. 1994. Handbook of Human Genetic Linkage. John Hopkins University Press, Baltimore. 307 pp.
34. Hasemann, J.K., and R. C. Elston. 1992. The investigation of linkage between a quantitative trait and a marker locus. Behav. Genet. 2:3-19.
35. S.A.G.E. Statistical Analysis for Genetic Epidemiology. Version 2.4 1994. System requirement: DOS. Louisiana State University Medical Center, New Orleans, LA.
36. Xu, C.-F., P. Talmud, H. Schuster, R. Houlston, G. Miller, and S. Humphries. 1994. Association between genetic variation at the Apo AI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin. Genet. 46:385-397.
37. Pagani, F., A. Sidoli, G.A. Giudici, L. Barenghi, C. Vergani, and F.E. Baralle. 1990. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J. Lipid Res. 31:1371-1377.
38. Talmud, P., S. Ye, and S.E. Humphries. 1994. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study. Genet. Epidemiol. 11:265-280.
39. Jeenah, M., A. Kessling, N. Miller, and S. Humphries. 1990. G to A substitution in the promotor region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I and high density lipoprotein cholesterol concentration. Mol. Biol. Med. 7:233-241.
40. Shoulders, C.C., P.J. Harry, L. Lagrost, S.E. White, N.F. Shah, J.D. North, M. Gilligan, P. Gambert, and M.J. Ball. 1991. Variation at the apo AI/ CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis. 87:239-247.
41. Rees, A., J. Stocks, L.G. Williams, J.L. Caplin, N.I. Jowett, A.J. Camm, and D.J. Galton. 1985. DNA polymorphism in the apolipoprotein C-III and insulin gene and atherosclerosis. Atherosclerosis. 58:269-275.
42. Dammerman, M., L.A. Sandkuyl, J.J. Halaas, W. Chung, and J.L. Breslow. 1993. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promotor and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. USA. 90:4562-4566.
43. Helio, T., A. Paliotie, T. Sane, M.J. Tikkanen, and K. Kontula. 1994. No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes. Hum. Genet. 94:271-278.
44. Paul-Hayase, H., M. Rosseneu, D. Robinson, J.P. v. Biervliet, J.P. Deslypere, and S.E. Humphries. 1992. Polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum. Genet. 88:439-446.
45. Rotter, J.I., C.E. Anderson, R. Rubin, J.E. Congleton, P.I. Terasaki, and D.L. Rimoin. 1983. HLA genotypic study of insulin-dependent diabetes. Diabetes. 32:169-174.
46. Thomson, G., W.P. Robinson, M.K. Kuhner, S. Joe, M.J. MacDonald, J.L. Goitschall, J. Barbosa, S.S. Rich, J. Bertrams, M.P. Baur, et al. 1988. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43: 799-816.
47. Rotter, J.I., C.M. Vadheim, and D.L. Rimoin. 1992. Diabetes mellitus. In The Genetic Basis of Common Diseases. R.A. King, J.I. Rotter, and A.G. Motulsky, editors. Oxford University Press, New York. 413-481.
48. Li, W.W., M.M. Dammerman, J.D. Smith, S. Metzger, J.L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96:2601-2605.
49. Surguchov, A.P., G.P. Page, L. Smith, W. Patsch, and E. Boerwinkle. 1996. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16:941-947.
50. Shoulders, C.C., T.T. Grantham, J.D. North, A. Gaspardone, F. Tomai, A. De Fazio, F. Versaci, P.A. Gioffre, and N.J. Cox. 1996. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children. Hum. Genet. 98:557-566.
51. Wu, D.-A., X. Bu, C.H. Warden, D.D.C. Shen, C.-Y. Yeng, W.H.H. Sheu, M.M.T. Fuh, T. Katsuya, V.J. Dzau, G.M. Reaven, et al. 1996. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J. Clin. Invest. 97:2111-2118.
52. Rotter, J.L. X.D. Bu, R.M. Cantor, C.H. Warden, J. Brown, R.J. Gray, P.J. Blanche, R.M. Krauss, and A.J. Lusis. 1996. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am. J. Hum. Genet. 58:585-594.